Higher levels of circulating CASP4 was detected in NSCLC patients than in healthy subjects, and higher levels of CASP4 in the tumor mass were associated to reduced overall survival compared to NSCLC patients with lower levels30. The gene discussed is CASP4; the disease is non-small cell lung carcinoma.